Stay updated on Volitinib for Primary CNS Tumors Clinical Trial

Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision identifier was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This appears to be a maintenance/metadata update rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-08-11T08:23:29.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new Phase I Savolitinib study title is added, expanding the scope to MET-activated CNS tumors and listing related drug names (Orpathys, HMPL504, AZD-6094). Minor eligibility wording changes (serum creatinine) and procedural updates (e.g., Sample Collection) are also reflected.
    Difference
    0.6%
    Check dated 2026-08-04T06:37:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a new build. The previous revision tag was removed.
    Difference
    0.0%
    Check dated 2026-07-28T04:14:06.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.2 to v3.6.3, signaling an update to the page template or platform components.
    Difference
    0.0%
    Check dated 2026-07-06T16:22:04.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Savolitinib study results have been posted and the study details have been updated. The Volitinib entry was removed, refocusing the page on the Savolitinib trial.
    Difference
    4%
    Check dated 2026-06-29T08:57:51.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now indicates the study is no longer recruiting participants. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label was standardized with a revision note (v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-15T08:34:18.000Z thumbnail image

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.